Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01295
|
|||||
| Drug Name |
Clobazam
|
|||||
| Synonyms |
Onfi; 1-Phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine; 1H-1,5-Benzodiazepine-2,4(3H,5H)-dione, 7-chloro-1-methyl-5-phenyl-; 22316-47-8; 7-Chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione; 7-chloro-1-methyl-5-phenyl-1,5-benzodiazepine-2,4-dione; BRN 0758410; CCRIS 7506; Chlorepin; Clobazam - Lundbeck; Clobazamum; Clobazamum [INN-Latin]; Clorepin; EINECS 244-908-7; Frisium; H 4723; H-4723; HR 376; LM 2717; LM-2717; NSC 336279; Onfi; RU-4723; UNII-2MRO291B4U; Urbadan; Urbanyl
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Epilepsy [ICD11: 8A6Z] | Approved | [1] | |||
| Therapeutic Class |
Neurology Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C16H13ClN2O2
|
|||||
| Canonical SMILES |
CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
|
|||||
| InChI |
InChI=1S/C16H13ClN2O2/c1-18-13-8-7-11(17)9-14(13)19(16(21)10-15(18)20)12-5-3-2-4-6-12/h2-9H,10H2,1H3
|
|||||
| InChIKey |
CXOXHMZGEKVPMT-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 22316-47-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 300.74 | Topological Polar Surface Area | 40.6 | ||
| Heavy Atom Count | 21 | Rotatable Bond Count | 1 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | |||
| XLogP |
2.1
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:31413
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Clobazam was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Tarascon Pocket Pharmacopoeia 2018 Classic Shirt-Pocket Edition. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.